# Michigan Genetic Hereditary Testing (MiGHT)

> **NCT05162846** · NA · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 831 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Ovarian Cancer
- Prostate Cancer
- Pancreatic Cancer
- Endometrial Cancer
- History of Cancer

## Interventions

- **OTHER:** Publicly available genetic testing resources
- **BEHAVIORAL:** Virtual genetics navigator
- **BEHAVIORAL:** Motivational interviewing (MI)

## Key facts

- **NCT ID:** NCT05162846
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-21
- **Primary completion:** 2025-07-13
- **Final completion:** 2025-11-21
- **Target enrollment:** 831 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05162846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05162846, "Michigan Genetic Hereditary Testing (MiGHT)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05162846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*